Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion

類似資料

• Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”
  著者:: Dan Călugăru, 等
  出版事項: (2017-09-01)
• Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”
  著者:: Călugăru, Dan, 等
  出版事項: (2017)
• Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion
  著者:: Wang, Hai-Yan, 等
  出版事項: (2011)
• Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
  著者:: Gutiérrez, Juan Carlos Mesa, 等
  出版事項: (2008)
• Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
  著者:: Yalamanchi, Shalini, 等
  出版事項: (2011)